Posted inCoronavirus Updates

Final analysis of efficacy: Covaxin 65.2% effective against Delta variant

Hyderabad: Bharat Biotech’s Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant. The company on Saturday said it concluded the final analysis of Covaxin efficacy from Phase 3 trials. The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptomatic COVID-19 […]